Delivery Order SPE2DR25D7066-SPE2DR26F7ZHC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) with a contract ceiling value of $5,317.71 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of November 28, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count unit) with a ceiling value of $1,487.88. This non-set-aside, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) with a ceiling value of $1,129.80. This firm fixed-price delivery order, with an ultimate completion date of November 5, 2025, represents a non-competitive set-aside award to support federal pharmaceutical procurement needs. The product will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Duloxetine HCL (delayed-release) 20 mg capsules in a quantity of 1,000 units, valued at $1,125.25 with firm fixed pricing. This delivery order represents a non-set-aside, competitively awarded contract with a completion date of November 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) with a contract value of $1,711.00 and a completion date of December 10, 2025. This firm fixed price delivery order represents a non-set-aside award issued under competitive procedures. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units) valued at $1,979.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction. The order is scheduled for ultimate completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,280.14 to AmerisourceBergen Drug Corp for Duloxetine HCL DR 60 mg capsules (30-count packaging) on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (90-count units) valued at $3,416.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 24, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition procurement process....
- The Defense Logistics Agency awarded a delivery order valued at $3,470.07 to AmerisourceBergen Drug Corp for the supply of 1,000 units of Duloxetine HCl DR 20 mg capsules. This order, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Duloxetine HCL (delayed-release) 30 mg capsules in a quantity of 1,000 units, with a contract ceiling value of $11,209.41. This non-set-aside delivery order employs firm fixed-price terms and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. The award represents a routine pharmaceutical...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZHCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of 1,000 units of Duloxetine HCl DR 30 mg capsules at a firm fixed price of $1,859.10. This is a non-set-aside competitive award with an ultimate completion date of November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company demonstrates extensive capability in fulfilling federal medical supply requirements through open competition, with a diverse portfolio spanning generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Duloxetine, a neurological medication, represents a routine transaction within the company's established relationship with the Defense Logistics Agency's Medical Supply Chain, supporting the Department of Defense's pharmaceutical distribution requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/25/25 |